AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
5.20
+0.06 (1.17%)
May 22, 2026, 4:00 PM EDT - Market closed
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.59 billion as of May 22, 2026. Its market cap has increased by 164.58% in one year.
Market Cap
1.59B
Enterprise Value
1.22B
1-Year Change
164.58%
Ranking
Category
Stock Price
$5.20
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.59B, a decrease of -89.87%. That is a compound annual growth rate of -34.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 1.59B | 55.06% |
| Dec 31, 2025 | 1.02B | 18.29% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunocore Holdings | 1.50B |
| AtaiBeckley | 1.50B |
| Vir Biotechnology | 1.50B |
| MBX Biosciences | 1.50B |
| UroGen Pharma | 1.47B |
| Damora Therapeutics | 1.46B |
| KalVista Pharmaceuticals | 1.43B |
| Maze Therapeutics | 1.39B |